BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 17468767)

  • 1. SIK1 is a class II HDAC kinase that promotes survival of skeletal myocytes.
    Berdeaux R; Goebel N; Banaszynski L; Takemori H; Wandless T; Shelton GD; Montminy M
    Nat Med; 2007 May; 13(5):597-603. PubMed ID: 17468767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CaM kinase IIdeltaC phosphorylation of 14-3-3beta in vascular smooth muscle cells: activation of class II HDAC repression.
    Ellis JJ; Valencia TG; Zeng H; Roberts LD; Deaton RA; Grant SR
    Mol Cell Biochem; 2003 Jan; 242(1-2):153-61. PubMed ID: 12619878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone deacetylase degradation and MEF2 activation promote the formation of slow-twitch myofibers.
    Potthoff MJ; Wu H; Arnold MA; Shelton JM; Backs J; McAnally J; Richardson JA; Bassel-Duby R; Olson EN
    J Clin Invest; 2007 Sep; 117(9):2459-67. PubMed ID: 17786239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of HDAC5 by SIK1 in AICAR-treated C2C12 myoblasts.
    Takemori H; Katoh Hashimoto Y; Nakae J; Olson EN; Okamoto M
    Endocr J; 2009; 56(1):121-30. PubMed ID: 18946175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of salt-inducible kinase 1 in the activation of MEF2-dependent transcription by BDNF.
    Finsterwald C; Carrard A; Martin JL
    PLoS One; 2013; 8(1):e54545. PubMed ID: 23349925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The transcriptional corepressor MITR is a signal-responsive inhibitor of myogenesis.
    Zhang CL; McKinsey TA; Olson EN
    Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7354-9. PubMed ID: 11390982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signal-dependent nuclear export of a histone deacetylase regulates muscle differentiation.
    McKinsey TA; Zhang CL; Lu J; Olson EN
    Nature; 2000 Nov; 408(6808):106-11. PubMed ID: 11081517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exercise and MEF2-HDAC interactions.
    McGee SL
    Appl Physiol Nutr Metab; 2007 Oct; 32(5):852-6. PubMed ID: 18059609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of class II histone deacetylases with heterochromatin protein 1: potential role for histone methylation in control of muscle differentiation.
    Zhang CL; McKinsey TA; Olson EN
    Mol Cell Biol; 2002 Oct; 22(20):7302-12. PubMed ID: 12242305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increases in intracellular sodium activate transcription and gene expression via the salt-inducible kinase 1 network in an atrial myocyte cell line.
    Popov S; Venetsanou K; Chedrese PJ; Pinto V; Takemori H; Franco-Cereceda A; Eriksson P; Mochizuki N; Soares-da-Silva P; Bertorello AM
    Am J Physiol Heart Circ Physiol; 2012 Jul; 303(1):H57-65. PubMed ID: 22467310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of skeletal myogenesis by association of the MEF2 transcription factor with class II histone deacetylases.
    Lu J; McKinsey TA; Zhang CL; Olson EN
    Mol Cell; 2000 Aug; 6(2):233-44. PubMed ID: 10983972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of recruitment of class II histone deacetylases by myocyte enhancer factor-2.
    Han A; He J; Wu Y; Liu JO; Chen L
    J Mol Biol; 2005 Jan; 345(1):91-102. PubMed ID: 15567413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dynamic role for HDAC7 in MEF2-mediated muscle differentiation.
    Dressel U; Bailey PJ; Wang SC; Downes M; Evans RM; Muscat GE
    J Biol Chem; 2001 May; 276(20):17007-13. PubMed ID: 11279209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective class II HDAC inhibitors impair myogenesis by modulating the stability and activity of HDAC-MEF2 complexes.
    Nebbioso A; Manzo F; Miceli M; Conte M; Manente L; Baldi A; De Luca A; Rotili D; Valente S; Mai A; Usiello A; Gronemeyer H; Altucci L
    EMBO Rep; 2009 Jul; 10(7):776-82. PubMed ID: 19498465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serine/Threonine Kinase 40 (Stk40) Functions as a Novel Regulator of Skeletal Muscle Differentiation.
    He K; Hu J; Yu H; Wang L; Tang F; Gu J; Ge L; Wang H; Li S; Hu P; Jin Y
    J Biol Chem; 2017 Jan; 292(1):351-360. PubMed ID: 27899448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase A-regulated assembly of a MEF2{middle dot}HDAC4 repressor complex controls c-Jun expression in vascular smooth muscle cells.
    Gordon JW; Pagiatakis C; Salma J; Du M; Andreucci JJ; Zhao J; Hou G; Perry RL; Dan Q; Courtman D; Bendeck MP; McDermott JC
    J Biol Chem; 2009 Jul; 284(28):19027-42. PubMed ID: 19389706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the myocyte enhancer factor-2 transcription factor by calcium/calmodulin-dependent protein kinase-stimulated binding of 14-3-3 to histone deacetylase 5.
    McKinsey TA; Zhang CL; Olson EN
    Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14400-5. PubMed ID: 11114197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinase D1 stimulates MEF2 activity in skeletal muscle and enhances muscle performance.
    Kim MS; Fielitz J; McAnally J; Shelton JM; Lemon DD; McKinsey TA; Richardson JA; Bassel-Duby R; Olson EN
    Mol Cell Biol; 2008 Jun; 28(11):3600-9. PubMed ID: 18378694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exercise and skeletal muscle glucose transporter 4 expression: molecular mechanisms.
    McGee SL; Hargreaves M
    Clin Exp Pharmacol Physiol; 2006 Apr; 33(4):395-9. PubMed ID: 16620308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The deacetylase HDAC4 controls myocyte enhancing factor-2-dependent structural gene expression in response to neural activity.
    Cohen TJ; Barrientos T; Hartman ZC; Garvey SM; Cox GA; Yao TP
    FASEB J; 2009 Jan; 23(1):99-106. PubMed ID: 18780762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.